XML 103 R64.htm IDEA: XBRL DOCUMENT v3.25.0.1

Employee Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2024

Retirement Benefits [Abstract]

Schedule of Stock Options Transactions

FNF stock option transactions under the Omnibus Plan for 2024, 2023, and 2022 are as follows:

			Options						Weighted Average Exercise Price						Exercisable
Balance, January 1, 2022			996,113						$	25.53					996,113
Exercised			(996,113)						25.53
Balance, December 31, 2022			—						$	—					—

FNF stock option transactions under the F&G Omnibus Plan for 2024, 2023, and 2022 are as follows:

			Options						Weighted Average Exercise Price						Exercisable
Balance January 1, 2022			1,527,936						$	35.97					1,072,584
Exercised			(352,614)						38.79
Canceled			(2,715)						28.00
Balance, December 31, 2022			1,172,607						$	35.15					1,172,607
Exercised			(502,414)						30.31
Canceled			(26,570)						38.07
Balance, December 31, 2023			643,623						$	38.80					643,623
Exercised			(543,623)						38.74
Balance, December 31, 2024			100,000						$	39.10					100,000

Schedule of Restricted Stock Transactions

FNF restricted stock transactions under the Omnibus Plan in 2024, 2023 and 2022 are as follows:

			Shares						Weighted Average Grant Date Fair Value
Balance, December 31, 2021			1,639,226						$	41.97
Granted			994,548						40.83
Vested			(792,230)						41.44
Balance, December 31, 2022			1,841,544						$	41.59
Granted			966,093						44.44
Canceled			(23,975)						41.42
Vested			(908,267)						40.26
Balance, December 31, 2023			1,875,395						$	43.69
Granted			1,604,119						60.23
Canceled			(16,603)						45.92
Vested			(1,105,691)						47.21
Balance, December 31, 2024			2,357,220						$	53.28

FNF restricted stock transactions under the F&G Omnibus Plan in 2024, 2023 and 2022 are as follows:

			Shares						Weighted Average Grant Date Fair Value
Balance, January 1, 2022			718,641						$	40.24
Granted			—						—
Canceled			(78,551)						37.79
Vested			(138,542)						34.11
Balance, December 31, 2022			501,548						$	42.31
Granted			—						—
Canceled			(15,965)						45.63
Vested			(304,104)						42.87
Balance, December 31, 2023			181,479						$	41.08
Granted			—						—
Canceled			(13,082)						48.28
Vested			(168,397)						40.53
Balance, December 31, 2024			—						$	—

Schedule of Stock Options Outstanding and Exercisable

The following table summarizes information related to stock options outstanding and exercisable as of December 31, 2024:

Options Outstanding

Options Exercisable

Weighted

Weighted

Average

Weighted

Average

Weighted

Remaining

Average

Remaining

Average

Range of

Number of

Contractual

Exercise

Intrinsic

Number of

Contractual

Exercise

Intrinsic

Exercise Prices

Options

Life

Price

Value

Options

Life

Price

Value

(In years)

(In millions)

(In years)

(In millions)

$0.00 - $39.10

100,000

0.97

$

39.10

$

2

100,000

0.97

$

39.10

$

2

100,000

$

2

100,000

$

2

X

- References

No definition available.

+ Details

Name:	us-gaap_CompensationAndRetirementDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration